Related Experiment Video
Updated: Aug 5, 2025

10:20
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
8.6K
Structural insights into the human niacin receptor HCA2-Gi signalling complex
Yang Yang1,2,3, Hye Jin Kang4,5, Ruogu Gao2,3
1iHuman Institute, ShanghaiTech University, Shanghai, 201210, China.
Nature Communications
|March 27, 2023
Summary
Niacin, a hydroxycarboxylic acid receptor 2 (HCA2) agonist, treats dyslipidemia but causes flushing. New structures reveal HCA2
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Hydroxycarboxylic acid receptor 2 (HCA2) agonists like niacin are used for dyslipidemia.
- Niacin's common side effect is skin flushing.
- Limited understanding of HCA2 signaling hinders development of safer alternatives.
Purpose of the Study:
- To elucidate the molecular basis of HCA2 signaling.
- To provide structural insights into HCA2 activation and ligand binding.
- To guide the discovery of novel HCA2-targeting drugs with improved safety profiles.
Main Methods:
- Cryo-electron microscopy (cryo-EM) to determine the structure of the HCA2-Gi signaling complex.
- X-ray crystallography to capture HCA2 in an inactive state.
- Comprehensive pharmacological analyses to understand receptor activation and signaling.
Main Results:
- Reported the cryo-EM structure of HCA2 bound to the potent agonist MK-6892.
- Determined crystal structures of HCA2 in its inactive conformation.
- Detailed the ligand binding mode, activation mechanism, and Gi signaling pathways of HCA2.
Conclusions:
- Structural and pharmacological data reveal key determinants of HCA2 signaling.
- Insights into HCA2 activation and ligand interaction are provided.
- This study offers a foundation for designing improved HCA2-targeting therapeutics for dyslipidemia.
More Related Videos
Related Concept Videos
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
G Protein-coupled Receptors
12.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.5K
Activation and Inactivation of G Proteins
7.3K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.3K
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
NF-κB-dependent Signaling Pathway
7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.7K
Cholinergic Receptors: Nicotinic
3.0K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
3.0K

